Drug-drug interaction with oral antivirals for the early treatment of COVID-19.
In: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Jg. 127 (2023-02-01), S. 171
Online
editorialOpinion
Zugriff:
Competing Interests: Declaration of competing interest AV has received consultancy fees from Amgen and Novartis. PTK has received consultancy fees, lecture honoraria, and/or travel fees from Amgen, Novartis, Raisio Group, and Sanofi. FR has received research grants, honoraria, or consulting fees for professional input and/or lectures from Sanofi, Regeneron, Amgen, and Novartis.
Titel: |
Drug-drug interaction with oral antivirals for the early treatment of COVID-19.
|
---|---|
Autor/in / Beteiligte Person: | Vuorio, A ; Raal, F ; Kovanen, PT |
Link: | |
Zeitschrift: | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Jg. 127 (2023-02-01), S. 171 |
Veröffentlichung: | Hamilton, ON : Elsevier ; <i>Original Publication</i>: Hamilton, ON : Decker, c1996-, 2023 |
Medientyp: | editorialOpinion |
ISSN: | 1878-3511 (electronic) |
DOI: | 10.1016/j.ijid.2022.11.039 |
Schlagwort: |
|
Sonstiges: |
|